These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1736981)

  • 1. Selection of young women with high-risk breast cancer for adjuvant systemic therapy.
    Stoll BA
    Clin Oncol (R Coll Radiol); 1992 Jan; 4(1):48-50. PubMed ID: 1736981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Should all younger patients with breast cancer be offered adjuvant cytotoxic chemotherapy?].
    Kroman NT; Jensen MB; Wohlfahrt J; Mouridsen H; Andersen PK; Melbye M
    Ugeskr Laeger; 2000 May; 162(22):3184-8. PubMed ID: 10850209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant systemic therapy for women with node-negative breast cancer. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer.
    CMAJ; 1998 Feb; 158 Suppl 3():S43-51. PubMed ID: 9484278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating the benefits of adjuvant systemic therapy for women with early breast cancer.
    Grogan M; Tabar L; Chua B; Chen HH; Boyages J
    Br J Surg; 2001 Nov; 88(11):1513-8. PubMed ID: 11683751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic overview of chemotherapy effects in breast cancer.
    Bergh J; Jönsson PE; Glimelius B; Nygren P;
    Acta Oncol; 2001; 40(2-3):253-81. PubMed ID: 11441936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant systemic therapy for women with node-positive breast cancer. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer.
    CMAJ; 1998 Feb; 158 Suppl 3():S52-64. PubMed ID: 9484279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical analysis of resectable breast cancer: a report of 6 263 cases].
    Yang MT; Rong TH; Huang ZF; Zeng CG; Long H; Fu JH; Lin P; Wang X; Wang SY; Wang X; Tang J
    Ai Zheng; 2005 Mar; 24(3):327-31. PubMed ID: 15757535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.
    Lancet; 1998 May; 351(9114):1451-67. PubMed ID: 9605801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-agent chemotherapy for early breast cancer.
    Early Breast Cancer Trialists' Collaborative Group
    Cochrane Database Syst Rev; 2002; (1):CD000487. PubMed ID: 11869577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved survival for women with stage I breast cancer in south-east Sweden: a comparison between two time periods before and after increased use of adjuvant systemic therapy.
    Johansson P; Fohlin H; Arnesson LG; Dufmats M; Nordenskjöld K; Nordenskjöld B; Stål O;
    Acta Oncol; 2009; 48(4):504-13. PubMed ID: 19235568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant chemotherapy in early breast cancer.
    Ejlertsen B
    Dan Med J; 2016 May; 63(5):. PubMed ID: 27127018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can we select which patients with small breast cancers should receive adjuvant chemotherapy?
    Wood WC; Anderson M; Lyles RH; Styblo TM; Murray D; Staley C; Yang L; Carlson G
    Ann Surg; 2002 Jun; 235(6):859-62. PubMed ID: 12035043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant therapy for breast cancer.
    NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time trends in systemic adjuvant treatment for node-negative breast cancer.
    Hébert-Croteau N; Brisson J; Latreille J; Gariépy G; Blanchette C; Deschênes L
    J Clin Oncol; 1999 May; 17(5):1458-64. PubMed ID: 10334531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant systemic therapy and survival after breast cancer.
    Olivotto IA; Bajdik CD; Plenderleith IH; Coppin CM; Gelmon KA; Jackson SM; Ragaz J; Wilson KS; Worth A
    N Engl J Med; 1994 Mar; 330(12):805-10. PubMed ID: 8114832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Micrometastases or isolated tumor cells and the outcome of breast cancer.
    de Boer M; van Deurzen CH; van Dijck JA; Borm GF; van Diest PJ; Adang EM; Nortier JW; Rutgers EJ; Seynaeve C; Menke-Pluymers MB; Bult P; Tjan-Heijnen VC
    N Engl J Med; 2009 Aug; 361(7):653-63. PubMed ID: 19675329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update.
    Krop I; Ismaila N; Andre F; Bast RC; Barlow W; Collyar DE; Hammond ME; Kuderer NM; Liu MC; Mennel RG; Van Poznak C; Wolff AC; Stearns V
    J Clin Oncol; 2017 Aug; 35(24):2838-2847. PubMed ID: 28692382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant therapy of primary breast cancer: a review of key findings from the 7th international conference, St. Gallen, February 2001.
    Aapro MS
    Oncologist; 2001; 6(4):376-85. PubMed ID: 11524557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tamoxifen for early breast cancer.
    Early Breast Cancer Trialists' Collaborative Group
    Cochrane Database Syst Rev; 2001; (1):CD000486. PubMed ID: 11279694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.